The National Institute for Health and Care Excellence has now approved capivasertib for use on the NHS - we look at who could ...

In trials, in 708 women, when combined with hormone therapy, the drug doubled the time the cancer took to grow, from 3.6 ...

A "huge breakthrough" in breast cancer treatment has arrived with the NHS approval of a twice-daily pill for the most common ...

Hormone receptor (HR)-positive HER2-negative advanced breast cancer is incurable and the aim of treatment is to delay it getting worse and extend how long people live. If the cancer has alterations in ...

Professor Nicholas Turner, from the Institute of Cancer Research, tells Sky News that capivasertib is a "great success story ...

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run ...

A new type of drug for one of the most common kinds of advanced breast cancer is now available on the NHS in England. Some 3,000 women a year could benefit from capivasertib after a clinical trial ...

A breakthrough cancer drug for those facing the advanced stages of the disease has been approved for the first time on the ...

A twice-a-day pill for advanced breast cancer has been approved for use on the NHS. The life-extending drug, called ...

A TWICE-a-day pill which slows or stops the most common type of advanced breast cancer has been approved for use on the NHS.

During a a live event, Virginia Kaklamani, MD, DSc, and participants discussed their experiences using a PI3K/AKT inhibitor ...